Y
Yin Chen
Researcher at Third Military Medical University
Publications - 17
Citations - 333
Yin Chen is an academic researcher from Third Military Medical University. The author has contributed to research in topics: Medicine & Chemistry. The author has an hindex of 7, co-authored 9 publications receiving 104 citations.
Papers
More filters
Journal ArticleDOI
Platelet-membrane-camouflaged bismuth sulfide nanorods for synergistic radio-photothermal therapy against cancer.
Yin Chen,Gaomei Zhao,Song Wang,Yongwu He,Yongwu He,Songling Han,Changhong Du,Shichao Li,Zhengli Fan,Cheng Wang,Junping Wang +10 more
TL;DR: This study demonstrates a versatile bismuth-containing nanoplatform with tumor-targeting, immune escape, and radiosensitizing functionalities using an autologous cell membrane biomimetic concept that may promote the development of radiotherapy enhancers.
Journal ArticleDOI
Human Cathelicidin Inhibits SARS-CoV-2 Infection: Killing Two Birds with One Stone.
Cheng Wang,Shaobo Wang,Daixi Li,Peiqin Chen,Songling Han,Gaomei Zhao,Yin Chen,Jianqi Zhao,Jiachuan Xiong,Jingfei Qiu,Dong-Qing Wei,Jinghong Zhao,Junping Wang +12 more
TL;DR: In this article, the authors showed that human cathelicidin LL37 can simultaneously block viral spike 1 (S1) protein with host angiotensin-converting enzyme-2 (ACE2) and cloak ACE2.
Journal ArticleDOI
Membrane Nanoparticles Derived from ACE2-Rich Cells Block SARS-CoV-2 Infection.
Cheng Wang,Shaobo Wang,Yin Chen,Jianqi Zhao,Songling Han,Gaomei Zhao,Jing Kang,Yong Liu,Liting Wang,Xiaoyang Wang,Yang Xu,Song Wang,Yi Huang,Junping Wang,Jinghong Zhao +14 more
TL;DR: In this paper, membrane nanoparticles (NPs) prepared from ACE2-rich human renal tubular epithelial cells were discovered to have potent capacity to block SARS-CoV-2 infection.
Journal ArticleDOI
Succinylated casein-coated peptide-mesoporous silica nanoparticles as an antibiotic against intestinal bacterial infection.
Gaomei Zhao,Yin Chen,Yongwu He,Fang Chen,Yali Gong,Shilei Chen,Yang Xu,Yongping Su,Cheng Wang,Junping Wang +9 more
TL;DR: A peptide-based nanobiotic with efficacy to combat intestinal infection, especially against drug-resistant bacteria is provided and the biocompatible and readily prepared MSN/SCN delivery system may benefit further intestinal antibiotic design and promote the drug transformation of additional enterogenic functional molecules.
Posted ContentDOI
Membrane Nanoparticles Derived from ACE2-rich Cells Block SARS-CoV-2 Infection
Cheng Wang,Shaobo Wang,Yin Chen,Jianqi Zhao,Songling Han,Gaomei Zhao,Jing Kang,Yong Liu,Liting Wang,Xiaoyang Wang,Yang Xu,Song Wang,Yi Huang,Junping Wang,Jinghong Zhao +14 more
TL;DR: This study demonstrates a easy-to-acheive memrbane nano-antagonist for curbing SARS-CoV-2, which enriches the existing antiviral arsenal and provides new possibilities to treat COVID-19.